Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients
Abstract Objective To evaluate the effectiveness of bazedoxifene in preventing bone loss in patients with rheumatoid arthritis (RA) receiving low-dose glucocorticoids (GCs). Methods In this randomized, controlled, open-label study, we assigned postmenopausal women with osteopenia who had been receiv...
Main Authors: | Soo-Kyung Cho, Hyoungyoung Kim, Jiyoung Lee, Eunwoo Nam, Seunghun Lee, Yun Young Choi, Yoon-Kyoung Sung |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-07-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-021-02564-1 |
Similar Items
-
Balancing the benefits and risks of low-dose glucocorticoid in rheumatoid arthritis.
by: Tânia Santiago, et al.
Published: (2015-01-01) -
Long-term treatment with low dose glucocorticoids in Rheumatoid Arthritis: New tricks of an old drug
by: Spyros N. Nikas
Published: (2018-01-01) -
GLUCOCORTICOIDS AND RHEUMATOID ARTHRITIS
by: Zhdan V. M., et al.
Published: (2020-12-01) -
Effects of conjugated estrogen and bazedoxifene on hemostasis and thrombosis in mice
by: Emmanuelle Noirrit, et al.
Published: (2019-06-01) -
Network Pharmacology Based Research on the Combination Mechanism Between Escin and Low Dose Glucocorticoids in Anti-rheumatoid Arthritis
by: Leiming Zhang, et al.
Published: (2019-03-01)